Evidence map›Paper›PMID 41930614›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Modeling small vessel disease burden and vascular dementia likelihood from NACC data.

Angelique D Gonzalez, Ali Ghaseminejad-Bandpey, Sudha Seshadri, Shahroo Etemadmoghadam, Margaret E Flanagan

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Angelique D GonzalezGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.ORCID 0009-0008-0653-136X
Ali Ghaseminejad-BandpeyGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
Shahroo EtemadmoghadamGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
Margaret E FlanaganGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.

Funding

The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)U19NS120384 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, MYRIAM FORNAGE · 2020 to 2026
$61.9M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Federated digital pathology platform for AD/ADRD research and diagnosticsU24NS133945 · NINDS · UNIVERSITY OF KENTUCKY · PI BUMGARDNER, CODY, FLANAGAN, MARGARET E · 2023 to 2025
$4.9M
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementiaRF1AG072080 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FLANAGAN, MARGARET E, POPKO, BRIAN J · 2021 to 2021
$2.2M
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementiaR01AG072080 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FLANAGAN, MARGARET E, POPKO, BRIAN J · 2024 to 2025
$1.4M
Baptist Foundation of San Antonio EndowmentNIA NIH HHS P30AG066546NIA NIH HHS R01AG072080NIA NIH HHS R01AG092118NIA NIH HHS RF1AG072080NIA NIH HHS U24NS133945NIH HHSNINDS NIH HHS R01NS017950NINDS NIH HHS U19NS120384NINDS NIH HHS U24NS133945Owen's Foundation Grantthe National Institutes of Neurological Disorders and Stroke
6 · The paper itself

Abstract

introductionCerebrovascular pathology contributes to dementia but lacks standardized quantification for multicenter datasets. We developed harmonized indices to quantify small vessel disease (SVD) and vascular cognitive impairment (VCI) likelihood using National Alzheimer's Coordinating Center Neuropathology 11 data.

methodsSix cerebrovascular domains were scored (0 to 3) and aggregated into a SVD index (0 to 18), with proportional scaling when ≥5 domains were available. A vascular cognitive impairment neuropathology guideline (VCING)-Lite proxy substituted global for occipital-specific ratings. A principal component analysis-derived global-cognition factor and clinical dementia status were modeled against vascular indices. Coherence was tested across complete, domain-complete, and Alzheimer's disease neuropathologic change (ADNC)-limited subsets.

resultsSVD scores were consistent across datasets, with lower values only in the ADNC-limited subset (p < 0.003). SVD-VCING-Lite correlations remained strong after adjustment (r = 0.72, p < 0.001). Both were associated with worse global cognition and higher odds of dementia. DISCUSSION: This framework links cerebrovascular pathology to in-life outcomes and enables reproducible modeling of vascular contributions in mixed dementias.

Indexed as

Cerebral Small Vessel DiseasesCognitive DysfunctionDementia, VascularAgedAged, 80 and overAlzheimer DiseaseBrainFemaleHumansMaleagingAlzheimer's diseasearteriolosclerosiscerebral amyloid angiopathydata harmonizationgross infarctsmicroinfarctsNational Alzheimer's Coordinating Centerneuropathologypost mortem human brainsmall vessel diseasevascular cognitive impairment and dementiavascular dementiavascular pathology

Identifiers

PMID41930614
PMCPMC13051914

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.